TRAUMA
Compliance to oral bisphosphonate therapy similar regardless of follow-up type
This report has been verified
by one or more authors of the
original publication.
Osteoporos Int. 2014 Apr;25(4):1345-55. doi: 10.1007/s00198-013-2610-4. Epub 2014 Jan 21.
102 patients with incident osteoporotic fractures were initiated on oral bisphosphonate therapy within a secondary fracture prevention program with subsequent management by either a specialist (Group A) or a primary care physician (Group B). Compliance and persistence to oral bisphosphonate therapy was determined over 2 years. Compliance and persistence were high, and did not significantly differ between groups. Thus treatment initiation in a secondary fracture prevention program is important to ensure optimal. compliance and persistence as opposed to type of follow-up routine.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
